Bypassing the LDL Receptor in Familial Hypercholesterolemia

  • Kersten, Sander Ph.D.

  • From the Division of Human Nutrition and Health, Wageningen University, Wageningen, the Netherlands.

Disclosure forms provided by the author are available with the full text of this editorial at NEJM.org.

New England Journal of Medicine 383(8):p 775-776, August 20, 2020. | DOI: 10.1056/NEJMe2023520

Evinacumab for Homozygous Familial Hypercholesterolemia

  • Raal, Frederick J. M.D., Ph.D.
  • Rosenson, Robert S. M.D.
  • Reeskamp, Laurens F. M.D.
  • Hovingh, Kees G. M.D., Ph.D.
  • Kastelein, John J.P. M.D., Ph.D.
  • Rubba, Paolo M.D.
  • Ali, Shazia Pharm.D.
  • Banerjee, Poulabi Ph.D.
  • Chan, Kuo-Chen Ph.D.
  • Gipe, Daniel A. M.D.
  • Khilla, Nagwa M.S.
  • Pordy, Robert M.D.
  • Weinreich, David M. M.D.
  • Yancopoulos, George D. M.D., Ph.D.
  • Zhang, Yi Ph.D.
  • Gaudet, Daniel M.D., Ph.D.
New England Journal of Medicine 383(8):p 711-720, August 20, 2020. | DOI: 10.1056/NEJMoa2004215
Copyright © 2020 Massachusetts Medical Society. All rights reserved.
View full text|Download PDF